Abstract
A new polymeric biomaterial that contains covalently bound iodine, and is therefore radiopaque, was used to construct a sustained local drug-delivery device. A polymeric wall was designed to be porous (i.e., passage of low-molecular-weight molecules across the wall is possible), self-healing, and biocompatible. Once implanted, the sphere cavity can be filled and refilled with a concentrated solution of a (cytostatic) drug, which is subsequently released by slow diffusion into the tissue region surrounding the sphere. This principle of sustained local drug delivery is shown by a series of in vitro experiments on the release of 5-fluorouracil, and in vivo animal experiments, using x-ray fluoroscopic and scintigraphic techniques.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Leroux, J.C., Doelker, E., and Gurny, R. 1996. The use of drug-loaded biodegradable nanoparticles in cancer chemotherapy, pp. 535–575 in Microencapsulation methods and industrial applications. Benita, S. (ed.), Marcel Dekker, New York.
Chasin, M. 1995. Biodegradable polymers for controlled drug delivery, pp. 1–15 in Biomedical applications of synthetic biodegradable polymers. Hollinger, J.O. (ed.), CRC Press, Boca Baton, FL.
Toguchi, H. 1992. Formulation study of leuprorelin acetate to improve clinical performance. Clin. Ther. 14: 121–129.
Tamada, J. and Langer, R. 1992. The development of polyanhydrides for drug delivery applications. J. Biom. Sci. (Polymer Ed.) 3: 305–353.
Brem, H., Piantadosi, S., Burger, P.C., Walker, M., Selker, R., Vick, N.A., et al. 1995. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 345: 1008–1012.
Walter, K.A., Tamargo, R.J., Olivi, A., Burger, P.C., and Brem, H. 1995. Intratumoral chemotherapy. Neurosurgery 37: 1129–1145.
Brem, H. and Langer, R. 1996. Polymer-based drug delivery to the brain. Science and Medicine 12: 52–61.
Chirila, T.V., Constable, I.J., Crawford, G.J., Vijayasekaran, S., Thompson, D.E., Chen, Y.C., et al. 1993. Poly(2-hydroxyethyl methacrylate) sponges as implant materials: in vivo and in vitro evaluations of cellular invasion. Biomaterials 14: 26–38.
Kruft, M.A.B., Benzina, A., Bär, F.H.M.W., van der Veen, F.H., Bastiaansen, C.W.M., Blezer, R., et al. 1994. Studies on two new radiopaque polymeric biomaterials. J. Biomed Mater. Res. 28: 1259–1266.
Moszner, N., Salz, V., Klestner, A.M., and Rheinberger, V. 1995. Synthesis and polymerisation of hydrophilic iodine-containing methacrylates. Angew. Makromol. Chem. 224: 115–123.
Kruft, M.A.B., Benzina, A., Blezer, R., and Koole, L.H. 1996. Studies on radiopaque polymeric biomaterials with potential applications to endovascular prostheses. Biomaterials 17: 1803–1812.
Benzina, A., Kruft, M.A.B., van der Veen, F.H., Bär, F.H.M.W., Blezer, R., Lindhout, M.J., et al. 1996. A versatile three-iodine molecular building block leading to new radiopaque polymeric biomaterials. J. Biomed. Mater. Res. 32: 459–466.
Davy, K.W.M., Anseau, M.R., Odlyha, M., and Foster, G.M. 1997. X-ray opaque methacrylate polymers for biomedical applications. Polymer International 43: 143–154.
Kruft, M.A.B., van der Veen, F.H., and Koole L.H. 1997. In vivo tissue compatibility of two radiopaque polymeric biomaterials. Biomaterials 18: 31–36.
Kruft, M.A.B. and Koole, L.H. 1996. A convenient method to measure monomer reactivity ratios. Applications to synthesis of polymeric biomaterials featuring intrinsic radiopacity. Macromolecules 29: 5513–5519.
Haaz, H.C., Fischel, J.L., Formento, P., Renee, N., Etienne, M.C., and Milano, G. 1996. Impact of different fluorouracil biochemical modulators on cellular dihydropyrimidine dehydrogenase. Cancer Chemother. Pharmacol. 38: 52–58.
Eatcock, M.M., Carlin, W., Dunlop, D.J., Soukop, M., and Watson, D.G. 1996. Bioavailability of subcutaneous 5-fluorouracil: a case report. Cancer Chemother. Pharmacol. 38: 110–112.
Drenth, W. and Kwart, H. 1982. Kinetics applied to organic reactions. Springer Verlag, Heidelberg.
Dionne, K.E., Cain, B.M., Li, R.H., Bell, W.J., Doherty, E.J., and Lysaght, M.J. 1996. Transport characterisation of membranes for immunoisolation. Biomaterials 17: 257–266.
Laurencin, C.T., Ibim, S.E.M., and Langer, R.S. 1995. Poly(anhydrides), pp. 59–102 in Biomedical applications of synthetic biodegradable polymers. Hollinger, J.O. (ed.), CRC Press, Boca Raton, FL.
Jain, R.K. 1994. Barriers to drug delivery in solid tumors. Sci. Am. 271: 58.
Jain, R.K. 1996. Delivery of molecular medicine to solid tumors. Science 271: 1079–1080.
Jain, R.K. 1996. Whitaker lecture: Delivery of molecular particles and cells to solid tumors. Ann. Biomed. Eng. 24: 457–473.
Giovanini, M.A. and Mickle, J.P. 1996. Long-term access tot cystic brain stem lesions with the Ommaya device: technical case report. Neurosurgery 39: 404–407.
Ommaya, A.K. 1984. Implantable devices for chronic access and drug delivery to the central nervous system. Cancer Drug Deliv. 1: 169–179.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Koole, L., Kruft, MA., Aldenhoff, Y. et al. Sustained local drug delivery from a radiopaque implanted reservoir. Nat Biotechnol 16, 172–176 (1998). https://doi.org/10.1038/nbt0298-172
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nbt0298-172